These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38477025)

  • 41. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound.
    Singh S; Pan C; Wood R; Yeh CR; Yeh S; Sha K; Krolewski JJ; Nastiuk KL
    BMC Urol; 2015 Sep; 15():97. PubMed ID: 26391476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [PI-RADS 2.0 for Prostate MRI].
    Franiel T; Röthke M
    Radiologe; 2017 Aug; 57(8):665-678. PubMed ID: 28721448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MR elastography to measure the effects of cancer and pathology fixation on prostate biomechanics, and comparison with T
    McGrath DM; Lee J; Foltz WD; Samavati N; van der Kwast T; Jewett MA; Chung P; Ménard C; Brock KK
    Phys Med Biol; 2017 Feb; 62(3):1126-1148. PubMed ID: 28092638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy.
    Sun C; Wang S; Chatterjee A; Medved M; Eggener S; Karczmar GS; Oto A
    Eur Radiol; 2021 Jan; 31(1):325-332. PubMed ID: 32785769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE.
    Lin YT; Amouyal G; Correas JM; Pereira H; Pellerin O; Del Giudice C; Déan C; Thiounn N; Sapoval M
    Eur Radiol; 2016 Oct; 26(10):3466-73. PubMed ID: 26738505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing signal-to-noise ratio for prostate imaging at 7T and 3T.
    Steensma BR; Luttje M; Voogt IJ; Klomp DWJ; Luijten PR; van den Berg CAT; Raaijmakers AJE
    J Magn Reson Imaging; 2019 May; 49(5):1446-1455. PubMed ID: 30350388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer.
    Daniel M; Kuess P; Andrzejewski P; Nyholm T; Helbich T; Polanec S; Dragschitz F; Goldner G; Georg D; Baltzer P
    Strahlenther Onkol; 2019 May; 195(5):402-411. PubMed ID: 30478670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?
    Walton Diaz A; Hoang AN; Turkbey B; Hong CW; Truong H; Sterling T; Rais-Bahrami S; Siddiqui MM; Stamatakis L; Vourganti S; Nix J; Logan J; Harris C; Weintraub M; Chua C; Merino MJ; Choyke P; Wood BJ; Pinto PA
    J Urol; 2013 Dec; 190(6):2020-2025. PubMed ID: 23792130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
    Miao H; Fukatsu H; Ishigaki T
    Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    Wu M; Krishna S; Thornhill RE; Flood TA; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Sep; 50(3):940-950. PubMed ID: 30701625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acoustic radiation force impulse imaging of human prostates ex vivo.
    Zhai L; Madden J; Foo WC; Palmeri ML; Mouraviev V; Polascik TJ; Nightingale KR
    Ultrasound Med Biol; 2010 Apr; 36(4):576-88. PubMed ID: 20350685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiparametric MRI of the anterior prostate gland: clinical-radiological-histopathological correlation.
    Moosavi B; Flood TA; Al-Dandan O; Breau RH; Cagiannos I; Morash C; Malone SC; Schieda N
    Clin Radiol; 2016 May; 71(5):405-17. PubMed ID: 26888762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Image quality and cancer visibility of T2-weighted magnetic resonance imaging of the prostate at 7 Tesla.
    Vos EK; Lagemaat MW; Barentsz JO; Fütterer JJ; Zámecnik P; Roozen H; Orzada S; Bitz AK; Maas MC; Scheenen TW
    Eur Radiol; 2014 Aug; 24(8):1950-8. PubMed ID: 24865699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
    Chang JH; Lim Joon D; Davis ID; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Bolton D; Scott AM; Khoo V
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):438-45. PubMed ID: 25864171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and imaging tools in the early diagnosis of prostate cancer, a review.
    De Visschere P; Oosterlinck W; De Meerleer G; Villeirs G
    JBR-BTR; 2010; 93(2):62-70. PubMed ID: 20524513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.
    Dinis Fernandes C; van Houdt PJ; Heijmink SWTPJ; Walraven I; Keesman R; Smolic M; Ghobadi G; van der Poel HG; Schoots IG; Pos FJ; van der Heide UA
    J Magn Reson Imaging; 2019 Jul; 50(1):269-278. PubMed ID: 30585368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
    Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
    Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.